Scientists hunt for hidden clues to stop prostate cancer treatment failures
NCT ID NCT04662996
Summary
This study aimed to find biological markers that could predict whether a patient's advanced prostate cancer would respond to specific treatments. Researchers analyzed tiny molecules called microRNAs in blood and tissue samples from 33 patients. The goal was to help doctors choose the most effective treatment right away, since 30-50% of patients currently don't benefit from their first treatment choice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Tours
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.